Home > Oncology > Radiation therapy, brachytherapy outcomes similar for localized prostate cancer

Radiation therapy, brachytherapy outcomes similar for localized prostate cancer


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
JAMA Network Open
Reuters Health - 07/10/2020 - Long-term survival among men with intermediate-risk prostate cancer did not differ regardless of whether they received stereotactic body radiation therapy (SBRT), dose-escalated external beam radiation (DE-EBRT) or brachytherapy (BT), according to a database analysis. "SBRT and BT should be the preferred treatment modalities for intermediate-risk prostate cancer," Dr. Albert Chang of the University of California, Los Angeles told Reuters Health by email. Yet, despite similar survival outcomes and the convenience and cost-effectiveness of SBRT and BT over DE-EBRT, he said, this study demonstrates that use of DE-EBRT "still dominates over SBRT and BT. Although the use of SBRT is increasing, BT utilization has significantly declined over the past decade." "The American Brachytherapy Society has launched a 'Brachytherapy Call to Arms' initiative to train 300 radiation oncologists to become competent in BT over the next 10 years," he noted. ...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on